Navigating Long-Term Medication Risks

This chapter explores the complexities surrounding long-term use of mental health medications like Ritalin and Adderall, emphasizing informed consent and the need for comprehensive data on potential risks. It critically examines the commercialization of ketamine treatments and the importance of seeking care from qualified providers over profit-driven clinics. Through personal anecdotes and tragic cases, the discussion underscores the significance of psychotherapy alongside medical treatments and the need for safe, supervised care.